{"id":"W4230932386","doi":"10.2165/00128413-200715990-00047","title":"Health Canada has granted expanded approval of lumiracoxib [Prexige; Novartis] for the treatment of acute and chronic osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Pharmacy; Alternative medicine; Physical therapy; Intensive care medicine; Family medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003549894,0.0001733346,0.0004971477,0.00006677816,0.00012187,0.000005680091,0.00006376172,0.00005425367,0.00002079613],"category_scores_gemma":[0.00001931837,0.0001187266,0.0000975451,0.0001348797,0.0001715516,0.0000360843,0.00001182484,0.00007800208,6.655749e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002375651,"about_ca_system_score_gemma":0.00110442,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03609322,"about_ca_topic_score_gemma":0.1140633,"domain_scores_codex":[0.998691,0.00003164137,0.0004605188,0.0001902231,0.0002568038,0.0003698694],"domain_scores_gemma":[0.9990129,0.0002534083,0.0002153615,0.0002300479,0.0001086387,0.0001795721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006021539,0.0008950658,0.01006244,0.002222728,0.001516084,0.0003639,0.005105261,0.0000162784,0.203005,0.0001226075,0.01925529,0.7514138],"study_design_scores_gemma":[0.03118721,0.01378213,0.03664337,0.0004225593,0.0007772549,0.0003645301,0.0005576571,0.001105973,0.8428256,0.00002319453,0.07195442,0.0003560836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890147,0.00619989,0.0005998177,0.001797669,0.0004326924,0.001746583,0.0001333624,0.0000194363,0.00005587039],"genre_scores_gemma":[0.9984612,0.0005587205,0.000163902,0.0002419052,0.0002909806,0.00007085668,0.00003367007,0.00002404587,0.000154667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7510577,"threshold_uncertainty_score":0.9703255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01777054040401422,"score_gpt":0.2917364214198742,"score_spread":0.2739658810158599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}